BriaPro is a pre-clinical stage immunotherapy company developing binding agents and proteins with the intention to boost the ability of the body’s own cancer-fighting cells to destroy cancerous tumors ...

Prime Day Sales US News UPenn developing ‘multivalent’ flu vaccine that could fight 20 strains By Katherine Donlevy Published Dec. 3, 2022, 8:05 p.m. ET ...

The "multivalent" vaccine, which the researchers describe in a paper published today in Science, uses the same messenger ribonucleic acid (mRNA) technology employed in the Pfizer and Moderna SARS ...

Multivalent protein vaccines produced using more traditional methods elicited fewer antibodies and were less protective compared to the multivalent mRNA vaccine in the animals.

For this reason, IAV has served as a model system to study multivalent ligand-receptor binding events, resulting in the discovery of potent bi-, tri-, and multivalent inhibitor compounds.

The formation of a multivalent assembly can rationally control the properties of molecular switches, improving their binding efficiency, modifying the drug release properties of DNA cargo ...

image: Caption: Multivalent cation additives modify the solvation structure of lithium or sodium cations in electrolytes and contribute to flat electrodeposition morphology. view more ...

Limmatech Biologics AG and Abvacc Inc. have entered into a license agreement that grants Limmatech the exclusive rights to further develop Abvacc’s multivalent toxoid vaccine candidate, LBT-SA7 ...

"Multivalent VHH-72 nanobodies also display drug-like biophysical properties - including high stability, high solubility, and low levels of non-specific binding", they add.

Multivalent batteries represent a significant advancement in battery technology, characterized by their use of multivalent ions (e.g., magnesium, calcium, or aluminum) instead of the monovalent ...

Journal Reference: Yanliang Liang, Hui Dong, Doron Aurbach, Yan Yao. Current status and future directions of multivalent metal-ion batteries. Nature Energy, 2020; DOI: 10.1038/s41560-020-0655-0 ...